Terazosin-md

Terazosin-md (compound TZ-md) is a derivative of Alfuzosin and Terazosin, functioning as an orally active α1-adrenergic receptor antagonist. It enhances mitochondrial metabolism, degrades various pathological protein deposits, and improves vascular endothelial cell function. Moreover, Terazosin-md has shown activity in mouse models of Alzheimer's disease. This compound can be utilized in the research of Alzheimer's disease, its complications, and disorders associated with protein aggregation and metabolic imbalances.